{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:44:21Z","timestamp":1766515461348,"version":"3.37.3"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Demographic changes lead to a number of issues regarding the biological treatment of older patients with moderate-to-severe psoriasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate the efficacy and safety of biologics in older adults, substratifying the population based on age, comorbidities and previous therapies over a longer timespan (&amp;gt; 60 weeks).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective, single-centre study was conducted with patients aged\u2005\u2265\u200565\u2005years with moderate-to-severe psoriasis who had been undergoing treatment with biologic drugs for\u2005&amp;gt;\u200560 weeks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Data for 130 patients aged \u2265 65\u2005years with moderate-to-severe psoriasis undergoing biologic therapy were reviewed: 45 were women and with a mean age of 73.23\u2005years (SD 6.53). The decline in mean Psoriasis Area and Severity Index (PASI), body surface area, Dermatology Life Quality Index and Nail Psoriasis Severity Index values over the 60 weeks of treatment was found to be statistically significant at each interval (P &amp;lt; 0.05). Multivariate statistical analysis showed that nearly all the independent variables considered did not influence the response to therapy in terms of PASI score reduction, except for psoriatic arthritis (P = 0.03). We observed a better response in the youngest-old group (aged 65\u201374\u2005years), with 73% (59\/81 patients) achieving \u2265 75% reduction in PASI (PASI 75) and 72% (58\/81 patients) achieving PASI 90 and PASI 100 at the 60th week of treatment. The worst result was obtained in the middle-old group (75\u201384\u2005years old), with 60.0% (24\/40 patients) reaching PASI 75 at the end of follow-up, whereas the oldest-old group (\u2265 85\u2005years) had a more mixed performance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The results obtained seem to indicate greater efficacy of anti-tumour necrosis factor-alpha drugs, followed by the other classes of interleukin inhibitors. These results could provide a starting point for new and larger studies and guidelines for biologic treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ced\/llae347","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T03:40:47Z","timestamp":1724816447000},"page":"573-579","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of biologics for the treatment of\u00a0moderate-to-severe psoriasis in older adults: a single-centre Italian experience"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3606-292X","authenticated-orcid":false,"given":"Filippo","family":"Viviani","sequence":"first","affiliation":[{"name":"Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi , Bologna ,","place":["Italy"]},{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Spazzoli","sequence":"additional","affiliation":[{"name":"Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi , Bologna ,","place":["Italy"]},{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Clarizio","sequence":"additional","affiliation":[{"name":"Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi , Bologna ,","place":["Italy"]},{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca Maria","family":"Piraccini","sequence":"additional","affiliation":[{"name":"Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi , Bologna ,","place":["Italy"]},{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Bardazzi","sequence":"additional","affiliation":[{"name":"Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi , Bologna ,","place":["Italy"]},{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"2025022416221776000_llae347-B1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"2025022416221776000_llae347-B2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/jamadermatol.2020.2311","article-title":"Effectiveness and safety of systemic therapy for psoriasis in older adults: a systematic review","volume":"156","author":"van Winden","year":"2020","journal-title":"JAMA Dermatol"},{"author":"World Health Organization","key":"2025022416221776000_llae347-B3"},{"author":"Eurostat","key":"2025022416221776000_llae347-B4"},{"key":"2025022416221776000_llae347-B5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/223965","article-title":"Age norms, age constraints, and adult socialization","volume":"70","author":"Neugarten","year":"1965","journal-title":"Am J Sociol"},{"key":"2025022416221776000_llae347-B6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.15441\/ceem.17.261","article-title":"Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department","volume":"5","author":"Lee","year":"2018","journal-title":"Clin Exp Emerg Med"},{"issue":"64A","key":"2025022416221776000_llae347-B7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/gerona\/gln045","article-title":"Total water intakes of community-living middle-old and oldest-old adults","author":"Zizza","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2025022416221776000_llae347-B8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1741-6612.2002.tb00418.x","article-title":"Evidence based medicine for older people: available, accessible, acceptable, adaptable?","volume":"21","author":"Nair","year":"2002","journal-title":"Australas J Ageing"},{"key":"2025022416221776000_llae347-B9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000345623","article-title":"Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study","volume":"225","author":"Esposito","year":"2012","journal-title":"Dermatology"},{"key":"2025022416221776000_llae347-B10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/1346-8138.12653","article-title":"Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis","volume":"41","author":"Hayashi","year":"2014","journal-title":"J\u00a0Dermatol"},{"key":"2025022416221776000_llae347-B11","doi-asserted-by":"crossref","first-page":"adv00316","DOI":"10.2340\/00015555-3678","article-title":"Effectiveness and safety of anti-interleukin-17 therapies in elderly patients with psoriasis","volume":"100","author":"Phan","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"2025022416221776000_llae347-B12","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2147\/CCID.S364640","article-title":"Guselkumab, risankizumab, and tildrakizumab in the management of psoriasis: a review of the real-world evidence","volume":"15","author":"Ruggiero","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2025022416221776000_llae347-B13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1203475419897578","article-title":"Biologic treatment in elderly patients with psoriasis: a systematic review","volume":"24","author":"Sandhu","year":"2020","journal-title":"J Cutan Med Surg"},{"key":"2025022416221776000_llae347-B14","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1080\/09546634.2020.1809623","article-title":"Elderly patients with psoriasis: long-term efficacy and safety of modern treatments","volume":"33","author":"Bakirtzi","year":"2022","journal-title":"J\u00a0Dermatol Treat"},{"key":"2025022416221776000_llae347-B15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10522-014-9514-3","article-title":"Innate immunesenescence: underlying mechanisms and clinical relevance","volume":"16","author":"Hazeldine","year":"2015","journal-title":"Biogerontology"},{"key":"2025022416221776000_llae347-B16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ad.2023.05.016","article-title":"Moderate to severe psoriasis in older adults: recommendations on management from the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology (AEDV)","volume":"114","author":"Mataix","year":"2023","journal-title":"Actas Dermosifiliogr"},{"key":"2025022416221776000_llae347-B17","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.5070\/D32410041706","article-title":"Incidence rates of comorbidities among patients with psoriasis in the United States","volume":"24","author":"Feldman","year":"2018","journal-title":"Dermatol Online J"},{"key":"2025022416221776000_llae347-B18","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/exd.14822","article-title":"Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis","volume":"32","author":"Rosset","year":"2023","journal-title":"Exp Dermatol"},{"key":"2025022416221776000_llae347-B19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.det.2020.12.012","article-title":"Nail psoriasis in older adults","volume":"39","author":"Ricardo","year":"2021","journal-title":"Dermatol Clin"},{"key":"2025022416221776000_llae347-B20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/14740338.2020.1728253","article-title":"Safety concerns with current treatments for psoriasis in the elderly","volume":"19","author":"Di Caprio","year":"2020","journal-title":"Expert Opin Drug Saf"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae347\/60916137\/llae347.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/3\/573\/60916137\/llae347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/3\/573\/60916137\/llae347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T16:22:28Z","timestamp":1740414148000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/3\/573\/7742846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,8,28]]},"published-print":{"date-parts":[[2025,2,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae347","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,8,28]]}}}